Evidence map›Paper›PMID 40866925›Full record

ArticleEuropean journal of medical research2025

Identification of a novel POU4F3 frameshift variant in a Chinese family with autosomal dominant hearing loss.

Jie Li, Shengmei Yang, Zonghui Feng, Xueshuang Huang, Genyun Tang, Youya Niu, Yunqi Yang, Bin Wang, Haiou Jiang

Abstract read
In one paragraph

Article in European journal of medical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jie Li *Institute of Biomedicine, School of Basic Medicine, School of Medical Humanities and Management, Hunan University of Medicine, Huaihua, China.
Shengmei Yang *Institute of Biomedicine, School of Basic Medicine, School of Medical Humanities and Management, Hunan University of Medicine, Huaihua, China.
Zonghui FengDepartment of Medical Genetics, Huaihua City Maternal and Child Health Care Hospital, Huaihua, China.
Xueshuang HuangInstitute of Biomedicine, School of Basic Medicine, School of Medical Humanities and Management, Hunan University of Medicine, Huaihua, China.
Genyun TangInstitute of Biomedicine, School of Basic Medicine, School of Medical Humanities and Management, Hunan University of Medicine, Huaihua, China.
Youya NiuInstitute of Biomedicine, School of Basic Medicine, School of Medical Humanities and Management, Hunan University of Medicine, Huaihua, China.
Yunqi YangTraditional Chinese Medicine Hospital of Chuxiong Yi Autonomous Prefecture, Chuxiong, China.
Bin WangKey Technology Engineering Center for New Veterinary Vaccine and Industry of Yunnan Provincial Education Department, Kunming University, Kunming, China. wangbbiomed@126.com.
Haiou JiangInstitute of Biomedicine, School of Basic Medicine, School of Medical Humanities and Management, Hunan University of Medicine, Huaihua, China. hhjiangh@126.com.

Funding

Key Project of Education Department of Hunan Province NO.23A0722Natural Science Foundation of Hunan Province NO.2024JJ7322Natural Science Foundation of Hunan Province NO.2025JJ70427
6 · The paper itself

Abstract

backgroundAutosomal dominant nonsyndromic hearing loss (ADNSHL) is characterised by highly clinical and genetic heterogeneity. A variant of POU4F3 is considered the pathogenic cause of ADNSHL, specifically designated as autosomal dominant nonsyndromic deafness 15 (DFNA15). The aim of this study was to explore the genetic variants and molecular pathogenic mechanism for a Chinese pedigree with DFNA15.

methodsA Chinese family with deafness underwent physical and otoscopic examinations, hearing measurements, and whole-exome sequencing. Sanger sequencing and segregation analysis were used to confirm the variants in the patients and healthy controls. The pathogenicity of the variants was detected using molecular modelling, immunoblotting and immunofluorescence experiments.

resultsThe patients showed bilateral, late-onset, progressive and sensorineural hearing loss without any other systemic diseases. Whole-exome and Sanger sequencing revealed a novel pathogenic variant, c.288dup, within the POU4F3 gene in the large Chinese family, which entirely cosegregated with the disease phenotype. The variant produced a truncated protein without functional domains, as determined using modelling, and theoretically destroyed the function of POU4F3. Immunofluorescence experiments revealed that the subcellular localisation of the mutant protein differed from that of wild-type protein, which could damage its normal function. In addition, immunoblotting experiments indicated that the mutant had lower protein expression than the wild type.

conclusionsWe first identified the frameshift variant (c.288dup, p.Ile97Hisfs*75) of POU4F3 associated with DFNA15. This study enriches the mutation spectrum of POU4F3 associated with hearing impairment and would help to illustrate the molecular pathogenic mechanism of POU4F3.

Indexed as

Frameshift MutationHearing Loss, SensorineuralHomeodomain ProteinsTranscription Factor Brn-3CAdultChinaEast Asian PeopleExome SequencingFemaleHumansMaleMiddle AgedPedigreeHomeodomain ProteinsPOU4F3 protein, humanTranscription Factor Brn-3CAutosomal dominant inheritanceNonsyndromic hearing lossPOU4F3Variant

Identifiers

PMID40866925
PMCPMC12382076

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.